Literature DB >> 11766873

Aetiology of respiratory tract infections: clinical assessment versus serological tests.

D Lieberman1, P Shvartzman, I Korsonsky, D Lieberman1.   

Abstract

Two hundred and fifty ambulatory patients with febrile respiratory tract infections were included in a prospective study, aimed at determining the reliability of physicians judgements relating to the aetiology of the infection. Compared with advanced serological testing, physicians' judgements for a bacterial/atypical, rather than viral, aetiology had a negative predictive value of 60% and a positive predictive value of only 50%. We conclude that physicians' ability to assess whether the infectious aetiology of RTI is viral or bacterial/atypical is low and no more reliable than tossing a coin.

Entities:  

Mesh:

Year:  2001        PMID: 11766873      PMCID: PMC1314193     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  4 in total

1.  Automated Detection of Streptococcus pyogenes Pharyngitis by Use of Colorex Strep A CHROMagar and WASPLab Artificial Intelligence Chromogenic Detection Module Software.

Authors:  Tam T Van; Kenneth Mata; Jennifer Dien Bard
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

2.  Evaluation of a combined MxA and CRP point-of-care immunoassay to identify viral and/or bacterial immune response in patients with acute febrile respiratory infection.

Authors:  Robert Sambursky; Nathan Shapiro
Journal:  Eur Clin Respir J       Date:  2015-12-10

3.  Outpatient Antibiotic Stewardship: A Growing Frontier-Combining Myxovirus Resistance Protein A With Other Biomarkers to Improve Antibiotic Use.

Authors:  Patrick Joseph; Eliot Godofsky
Journal:  Open Forum Infect Dis       Date:  2018-02-15       Impact factor: 3.835

4.  A prospective, community-based study on virologic assessment among elderly people with and without symptoms of acute respiratory infection.

Authors:  Judith M Graat; Evert G Schouten; Marie-Louise A Heijnen; Frans J Kok; Esther G M Pallast; Sabine C de Greeff; J Wendelien Dorigo-Zetsma
Journal:  J Clin Epidemiol       Date:  2003-12       Impact factor: 6.437

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.